Late-stage American biopharmaceutical companies in late-stage development for their product are logically interested in the European market, and we clearly see a trend of companies looking to expand in Europe by themselves rather than partnering with an establishment based there.…
The promotion of medicinal products is governed by advertising laws and regulations in the European Union (EU). In particular, the Directive 2001/83/EC ‘of the European parliament and of the Council of 6 November 2001 on the Community code relating to…
Two pharmaceutical companies sought solutions for review of promotional and non-promotional materials to ensure compliance with the European Union (EU) and national country legislation and guidelines for medicinal products. The objective for BlueReg was to provide provide a sustainable,…
BlueReg supported a US‑based client with its promotional launch campaign in Europe for their new medicinal product.BlueReg provided full coverage for all aspects of setting up and coordinating the global and local reviews of the various promotional items of the…
Our experts at BlueReg are giving advice on how to effectively manage your promotional compliance for pharmaceutical products in EU & beyond. The different subjects discussed in the webinar are : Why is your promotional campaign key to the success…